{
    "2019-05-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Gilead Sciences Slips on Goldman's Downgrade to Sell",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Sciences",
                        "Slips",
                        "Goldman",
                        "Downgrade",
                        "Sell"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy",
                "features": {
                    "keywords": [
                        "Goldman",
                        "Sachs",
                        "Picks",
                        "Big",
                        "Pharma",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "J&J Stock Up This Year So Far: Will the Momentum Continue?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stock",
                        "Up",
                        "Momentum",
                        "Continue"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "This 5% Dividend Yield Isn't Good Enough for Me",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Yield",
                        "Good",
                        "Enough"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}